These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27181204)

  • 1. The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
    Mendoza-Villanueva D; Balamurugan K; Ali HR; Kim SR; Sharan S; Johnson RC; Merchant AS; Caldas C; Landberg G; Sterneck E
    Oncogene; 2016 Dec; 35(48):6166-6176. PubMed ID: 27181204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes.
    Balamurugan K; Mendoza-Villanueva D; Sharan S; Summers GH; Dobrolecki LE; Lewis MT; Sterneck E
    Oncogene; 2019 May; 38(20):3765-3780. PubMed ID: 30262865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
    Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
    Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.
    Balamurugan K; Wang JM; Tsai HH; Sharan S; Anver M; Leighty R; Sterneck E
    EMBO J; 2010 Dec; 29(24):4106-17. PubMed ID: 21076392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: I. "Loss of function" alterations in the c/EBPdelta growth inhibitory pathway in breast cancer cell lines.
    Sivko GS; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):830-43. PubMed ID: 15389879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
    Tang D; Sivko GS; DeWille JW
    Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma.
    Sowamber R; Chehade R; Bitar M; Dodds LV; Milea A; Slomovitz B; Shaw PA; George SHL
    EBioMedicine; 2019 Jun; 44():261-274. PubMed ID: 31078521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4.
    Balamurugan K; Sharan S; Klarmann KD; Zhang Y; Coppola V; Summers GH; Roger T; Morrison DK; Keller JR; Sterneck E
    Nat Commun; 2013; 4():1662. PubMed ID: 23575666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C/EBP{delta} targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression.
    Pawar SA; Sarkar TR; Balamurugan K; Sharan S; Wang J; Zhang Y; Dowdy SF; Huang AM; Sterneck E
    Proc Natl Acad Sci U S A; 2010 May; 107(20):9210-5. PubMed ID: 20439707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PERK signaling through C/EBPδ contributes to ER stress-induced expression of immunomodulatory and tumor promoting chemokines by cancer cells.
    Sheshadri N; Poria DK; Sharan S; Hu Y; Yan C; Koparde VN; Balamurugan K; Sterneck E
    Cell Death Dis; 2021 Nov; 12(11):1038. PubMed ID: 34725321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
    Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
    Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCAAT/Enhancer binding protein delta (c/EBPdelta) regulation and expression in human mammary epithelial cells: II. Analysis of activating signal transduction pathways, transcriptional, post-transcriptional, and post-translational control.
    Sivko GS; Sanford DC; Dearth LD; Tang D; DeWille JW
    J Cell Biochem; 2004 Nov; 93(4):844-56. PubMed ID: 15389878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
    Milde-Langosch K; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C/EBPδ: friend or foe? a novel role for C/EBPδ in metastasis.
    Pelorosso FG; Balmain A
    EMBO J; 2010 Dec; 29(24):4063-5. PubMed ID: 21157479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancer.
    Thaler S; Thiede G; Hengstler JG; Schad A; Schmidt M; Sleeman JP
    Int J Cancer; 2015 Aug; 137(3):686-97. PubMed ID: 25530422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCAAT/enhancer-binding protein delta: a molecular target of 1,25-dihydroxyvitamin D3 in androgen-responsive prostate cancer LNCaP cells.
    Ikezoe T; Gery S; Yin D; O'Kelly J; Binderup L; Lemp N; Taguchi H; Koeffler HP
    Cancer Res; 2005 Jun; 65(11):4762-8. PubMed ID: 15930295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.
    Liu BW; Yu ZH; Chen AX; Chi JR; Ge J; Yu Y; Cao XC
    J Exp Clin Cancer Res; 2019 Mar; 38(1):109. PubMed ID: 30823890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions between CCAAT enhancer binding protein delta and estrogen receptor alpha control insulin-like growth factor I (igf1) and estrogen receptor-dependent gene expression in osteoblasts.
    Chang W; Parra M; Centrella M; McCarthy TL
    Gene; 2005 Jan; 345(2):225-35. PubMed ID: 15716114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C/EBPδ-Slug-Lox1 axis promotes metastasis of lung adenocarcinoma via oxLDL uptake.
    Wang D; Cheng X; Li Y; Guo M; Zhao W; Qiu J; Zheng Y; Meng M; Ping X; Chen X; Wang S; Luo J; Luo Q; Ma X; Xu L
    Oncogene; 2020 Jan; 39(4):833-848. PubMed ID: 31562393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.